Portal de Periódicos da CAPES

The Role of IL‐12 in the Pathogenesis of Thl Cell‐Mediated Autoimmune Diseases

1996; Wiley; Volume: 795; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1996.tb52670.x

1749-6632

Luciano Adorini, Silvia Gregori, Jeanne Magram, Sylvie Trembleau,

T-cell and B-cell Immunology

Annals of the New York Academy of SciencesVolume 795, Issue 1 p. 208-215 The Role of IL-12 in the Pathogenesis of Thl Cell-Mediated Autoimmune Diseases LUCIANO ADORINI, LUCIANO ADORINI Roche Milano Ricerche, Via Olgettina 58, 1-20132 Milano, ItalySearch for more papers by this authorSILVIA GREGORI, SILVIA GREGORI Roche Milano Ricerche, Via Olgettina 58, 1-20132 Milano, ItalySearch for more papers by this authorJEANNE MAGRAM, JEANNE MAGRAM Department of Biotechnology, Hoffmann-La Roche Inc., Nutley, New Jersey 07110Search for more papers by this authorSYLVIE TREMBLEAU, SYLVIE TREMBLEAU Roche Milano Ricerche, Via Olgettina 58, 1-20132 Milano, ItalySearch for more papers by this author LUCIANO ADORINI, LUCIANO ADORINI Roche Milano Ricerche, Via Olgettina 58, 1-20132 Milano, ItalySearch for more papers by this authorSILVIA GREGORI, SILVIA GREGORI Roche Milano Ricerche, Via Olgettina 58, 1-20132 Milano, ItalySearch for more papers by this authorJEANNE MAGRAM, JEANNE MAGRAM Department of Biotechnology, Hoffmann-La Roche Inc., Nutley, New Jersey 07110Search for more papers by this authorSYLVIE TREMBLEAU, SYLVIE TREMBLEAU Roche Milano Ricerche, Via Olgettina 58, 1-20132 Milano, ItalySearch for more papers by this author First published: October 1996 https://doi.org/10.1111/j.1749-6632.1996.tb52670.xCitations: 17AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin & R. L. Coffmann. 1986. Two types of murine helper T cell clone. I. Definition according to profile of lymphokine activities and secreted proteins. J. Immunol. 136: 2348–2357. 2 Del Prete, G., M. De Carli, C. Mastromauro, R. Biagiotti, D. Macchia, P. Falagiani, M. Ricci & S. Romagnani. 1991. Purified protein derivative of mycobacterium tuberculosis and escretory-secretory antigen(s) of toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest. 88: 346–350. 3 Romagnani, S. 1991. Human TH1 and TH2: Doubt no more. Immunol. Today. 12: 256–257. 4 Reiner, S. L. & R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13: 151–177. 5 Trinchieri, G. 1995. Interleukin 12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13: 251–276. 6 Paul, W. E. & R. A. Seder. 1994. Lymphocyte responses and cytokines. Cell 76: 241–251. 7 Pfeiffer, C., J. Stein, S. Southwood, H. Ketelaar, A. Sette & K. Bottomly. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181: 1569–1574. 8 Kumar, V., V. Bhardwaj, L. Soares, J. Alexander, A. Sette & E. Sercarz. 1995. Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon γ by T cells. Proc. Natl. Acad. Sci. USA 92: 9510–9514. 9 Hsieh, C.-S., S. E. Macatonia, C. S. Tripp, S. F. Wolf, A. O'Garra & K. M. Murphy. 1993. Development of Thl CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547–549. 10 Manetti, R., P. Parronchi, M. G. Giudizi, M.-P. Piccinni, E. Maggi, G. Trinchieri & S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12, IL-12) induces T helper type 1 (Thl)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177: 1199–1204. 11 Afonso, L. C. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri & P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263: 235–237. 12 Kiniwa, M., M. Gately, U. Gubler, R. Chizzonite, C. Fargeas & G. Delespesse. 1992. Recombinant interleukin-12 suppresses the synthesis of IgE by interleukin-4 stimulated human lymphocytes. J. Clin. Invest. 90: 262–266. 13 Schmitt, E., P. Hoehn, C. Huels, S. Goedert, N. Palm, E. Ruede & T. Germann. 1994. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur. J. Immunol. 24: 793–798. 14 Gajewski, T. F. & F. W. Fitch. 1988. Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Thl murine helper T lymphocyte clones. J. Immunol. 140: 4245–4253. 15 Moore, K., A. O'Garra, R. de Waal Malefyt, P. Vieira & T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11: 165–190. 16 D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin & G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178: 1041–1048. 17 de Waal Malefyt, R., C. G. Figdor, R. Huijbens, S. Mohan-Peterson, B. Bennett, J. Culpepper, W. Dang, G. Zurawski & J. E. de Vries. 1993. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-γ or IL-10. J. Immunol. 151: 6370–6381. 18 D'Andrea, A., X. Ma, A. Aste-Amezaga, C. Paganin & G. Trinchieri. 1995. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: Priming for IL-12 and tumor necrosis factor a production. J. Exp. Med. 181: 537–546. 19 Powrie, F. & R. L. Coffmann. 1993. Cytokine regulation of T cell function: Potential for therapeutic intervention. Immunol. Today 14: 270–274. 20 O'Garra, A. & K. Murphy. 1993. T-cell subsets in autoimmunity. Curr. Opin. Immunol. 5: 880–886. 21 Liblau, R. S., S. M. Singer & H. O. McDevitt. 1995. Thl and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16: 34–38. 22 Trembleau, S., T. Germann, M. K. Gately & L. Adorini. 1995. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today 16: 383–386. 23 Ando, D. G., J. Clayton, D. Kong, J. L. Urban & E. E. Sercarz. 1989. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Thl lymphokine subtype. Cell. Immunol. 124: 132–143. 24 Haskins, K. & M. McDuffie. 1990. Acceleration of diabetes in young NOD mice with a CD4+ islet specific T cell clone. Science 249: 1433–1436. 25 Akhtar, I., J. P. Gold, L.-Y. Pan, J. L. Ferrara, X.-D. Yang, J. I. Kim & K.-N. Tan. 1995. CD4+β islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 182: 87–97. 26 Yang, X.D., R. Tisch, S. M. Singer, Z. A. Cao, R. S. Liblau, R. D. Schreiber & H. O. McDevitt. 1994. Effect of tumor necrosis factor α on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process, J. Exp. Med. 180: 995–1004. 27 Wogesen, L., M.-S. Lee & N. Sarvetnick. 1994. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J. Exp. Med. 179: 1379–1384. 28 Rapoport, M. J., A. Jaramillo, D. Zipris, A. H. Lazarus, D. V. Serreze, E. H. Leiter, P. Cyopick, J. S. Danska & T. L. Delovitch. 1993. Interleukin 4 reverses T-cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178: 87–99. 29 Pennline, K. J., E. Roquegaffney & M. Monahan. 1994. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71: 169–175. 30 Fowell, D. & D. Mason. 1993. Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential. J. Exp. Med. 177: 627–636. 31 Scott, B., R. Liblau, S. Degermann, L. A. Marconi, L. Ogata, A. J. Caton, H. O. McDevitt & D. Lo. 1994. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1: 1–20. 32 Racke, M. K., A. Bonomo, D. E. Scott, B. Cannella, A. Levine, C. S. Raine, E. M. Shevach & M. Roecken. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180: 1961–1966. 33 Allen, J. B., H. L. Wong, G. L. Costa, M. J. Bienkowski & S. M. Wahl. 1993. Suppression of monocyte function and differential regulation of IL-1 and lL-lra by IL-4 contribute to resolution of experimental arthritis. J. Immunol. 151: 4344–4351. 34 Saoudi, A., J. Kuhn, K. Huygen, Y. de Kozak, T. Velu, M. Goldman, P. Druet & B. Bellon. 1993. TH2-activated cells prevent experimental autoimmune uveoretinitis, a THl-dependent autoimmune disease. Eur. J. Immunol. 23: 3096–3103. 35 Katz, J.D., C Benoist & D. Mathis. 1995. T helper cell subsets in insulin-dependent diabetes. Science 268: 1185–1188. 36 Moritani, M., K. Yoshimoto, F. Tashiro, C. Hashimoto, J. Miyazaki, S. Ii, E. Kudo, H. Izahana, Y. Hayashi, T. Sano & M. Itakura. 1994. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int. Immunol. 6: 1927–1936. 37 Wolf, S. F., P. A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, D. Ferenz, R. M. Hewick, H. Kelleher, S. H. Herrmann, S. C. Clark, L. Azzoni, S. H. Chan, G. Trinchieri & B. Perussia. 1991. Cloning of cDNA for natural killer stimulatory factor, a heterodimeric cytokine with multiple biological effects on T and natural killer cells. J. Immunol. 146: 3074–3081. 38 Gubler, U., A. O. Chua, D. S. Schoenhaut, C. M. Dwyer, W. McComas, R. Motyka, N. Nabavi, A. G. Wolitzky, P. M. Quinn, P. C Familletti & M. K. Gately. 1991. Coexpression of two distinct genes is required to generate secreted, bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88: 4143–4147. 39 Trinchieri, G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84: 4008–4027. 40 Germann, T., M. Gately, D. S. Schoenhaut, M. Lohoff, F. Mattner, S. Fischer, S. C Jin, E. Schmitt & E. Rude. 1993. Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Thl) but not on Th2 cells. Eur. J. Immunol. 23: 1762–1770. 41 Trembleau, S., G. Penna, E. Bosi, A. Mortara, M. K. Gately & L. Adorini. 1995. IL-12 administration induces Thl cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181: 817–821. 42 O'Hara, R. M. & S.L. Henderson. 1995. Interleukin 12 prevents the onset of diabetes in NOD mice. FASEB J. 9: 5938. 43 Leonard, J. P., K. E. Waldburger & S.J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin-12. J. Exp. Med. 181: 381–386. 44 Germann, T., J. Szeliga, H. Hess, S. Stoerkel, F. J. Podlaski, M. K. Gately, E. Schmitt & E. Ruede. 1995. Administration of IL-12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc. Natl. Acad. Sci. USA 92: 4823–4827. 45 Neurath, M. F., I. Fuss, B. L. Kelsall, E. Stueber & W. Strober. 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182: 1281–1290. 46 Murphy, E. E., G. Terres, S. E. Macatonia, C.-S. Hsieh, J. Mattson, L. Lanier, M. Wysocka, G. Trinchieri, K. Murphy & A. O'Garra. 1994. B7 and interleukin 12 cooperate for proliferation and interferon γ production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180: 223–231. Citing Literature Volume795, Issue1Interleukin 12: Cellular and Molecular Immunology of an Important Regulatory CytokineOctober 1996Pages 208-215 ReferencesRelatedInformation